Factors associated with health care utilization in pediatric multiple sclerosis

Ruth Ann Marrie1, Julia O'Mahony2, Colleen Maxwell3

  • 1Departments of Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Insights

In pediatric multiple sclerosis (MS), more relapses predict hospitalizations, and better cognitive function reduces physician visits. Health-related quality of life (HRQOL) did not explain physician visit disparities in children with MS compared to healthy peers.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Health Services Research

Background:

  • Children with multiple sclerosis (MS) face unique healthcare challenges.
  • Understanding factors influencing hospitalizations and physician visits is crucial for managing pediatric MS.
  • Assessing health-related quality of life (HRQOL) alongside clinical factors provides a comprehensive view.

Purpose of the Study:

  • To determine if clinical characteristics and HRQOL independently predict hospitalizations and physician visits in children with MS.
  • To investigate whether HRQOL differences explain variations in physician visits among children with MS, monophasic acquired demyelinating syndromes (ADS), and healthy controls.

Main Methods:

  • Utilized linked administrative health data and a prospective cohort study in Ontario, Canada.
  • Collected data on HRQOL (PedsQL), cognitive function, relapses, and neurologic status.
  • Employed generalized linear models with generalized estimating equations to analyze factors associated with healthcare utilization.

Main Results:

  • Among children with MS, increased relapses correlated with higher hospitalization odds (OR 1.59).
  • Better cognitive accuracy scores were linked to fewer physician visits (RR 0.68).
  • Children with MS had more physician visits than healthy controls (RR 1.44), but HRQOL did not account for this difference.

Conclusions:

  • In pediatric MS, disease activity (relapses) and cognitive function significantly impact healthcare utilization.
  • HRQOL does not appear to mediate the increased physician visit rates observed in children with MS compared to healthy children.
Abstract

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.9K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
824
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215